![]() Albumedix Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases. | ![]() Escient Pharmaceuticals Escient Pharmaceuticals is a biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications. | ![]() Ventria Bioscience Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases. | United Biomedical United Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. | DiscGenics DiscGenics is a biopharmaceutical company focused on developing regenerative therapies for patients with diseases of the spine. | |
Founding Date | Founding Date 2016 | Founding Date N/A | Founding Date 1993 | Founding Date 1985 | Founding Date 2007 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Nottinghamshire, GB HQ Nottingham, GB | Locations San Diego, US HQ | Locations Junction City, US HQ Aurora, US | Locations Salt Lake City, US HQ Salt Lake City, US | |
Employees | Employees 801% decrease | Employees 403% increase | Employees 356% increase | Employees 464% decrease | Employees 4014% increase |
Twitter followers | Twitter followers 24 | Twitter followers N/A | Twitter followers N/A | Twitter followers N/A | Twitter followers 205 |
Alexa Website Rank | Alexa Website Rank 206361 | Alexa Website Rank 136663 | Alexa Website Rank N/A | Alexa Website Rank 160821 | Alexa Website Rank 183526 |
Employee Rating | Employee Rating 3.6 | Employee Rating N/A | Employee Rating 4.2 | Employee Rating 2.6 | Employee Rating 5 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 77.5m (almost 2 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 50m (almost 2 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 117.5m | Total funding raised $ 7.7m | Total funding raised N/A | Total funding raised $ 68m |
Escient Pharmaceuticals is a biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications.
View companyVentria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.
View companyUnited Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.
View companyDiscGenics is a biopharmaceutical company focused on developing regenerative therapies for patients with diseases of the spine.
View company